NCT03911024 is a NA clinical trial of HIV in Behavior, Risk, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT03911024?

NCT03911024 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT03911024?

Interventions in NCT03911024: HIV, General health.

What condition does NCT03911024 study?

NCT03911024 studies Behavior, Risk.

Is NCT03911024 still recruiting?

NCT03911024 is currently completed. Last updated 17 October 2019.

Last reviewed 2019-10-17 · How we verify

NCT03911024

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness and Unstable Housing

Completed NA Last updated 17 October 2019

What this trial tests

NA trial testing HIV in Behavior, Risk in 100 participants. Completed in 1 August 2019.

Timeline

20 May 2019

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	100
Start date	20 May 2019
Primary completion	1 August 2019
Estimated completion	1 August 2019
Sites	1 location across United States

Drugs / interventions tested

HIV — full drug profile →
General health

Conditions studied

Behavior, Risk — all drugs for Behavior, Risk →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 18 to 25, any sex, with Behavior, Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is develop and pilot test a personalized HIV intervention with youth experiencing homelessness by creating and field testing prevention messages that address real-time predictors (e.g., sexual urge, use to use drugs, and substance use) of HIV risk behaviors,to evaluate the feasibility and acceptability of the intervention and to evaluate the intervention outcome effects on HIV risk behaviors (e.g., condomless sex, number of sexual partners, pre-exposure prophylaxis(PrEP) awareness, substance use during sex,Intravenous(IV)drug use)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of a Just-in-Time Adaptive Intervention to Promote HIV Risk Reduction Behaviors Among Young Adults Experiencing Homelessness: Pilot Randomized Controlled Trial.
Santa Maria D, Padhye N, Businelle M, Yang Y, et al · · 2021 · cited 22× · PMID 34255679 · DOI 10.2196/26704

Verify or expand the search:

Other trials of HIV

Trials testing the same drug.

NCT06489860 — SARS-CoV-2 Safety Study for the Treatment of COVID-19 · Phase 2 · withdrawn
NCT04087239 — The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study · active not recruiting

Other recruiting trials for Behavior, Risk

Currently open trials in the same condition.

NCT07320664 — Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women · NA · recruiting
NCT06192316 — Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior · NA · recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03911024 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 17 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03911024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing